MARKET WIRE NEWS

Traws Pharma, Inc. (TRAW) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-14 13:14:30 ET

Traws Pharma, Inc. (TRAW)

Q2 2025 Earnings Conference Call

August 14, 2025, 8:30 AM ET

Company Participants

Charles Parker - Interim Chief Financial Officer

David Pauza - Corporate Participant

Iain D. Dukes - Interim CEO, Secretary & Director

Robert R. Redfield - Chief Medical Officer

Conference Call Participants

John P. Fraunces - Lifesci Advisors, LLC

Presentation

Operator

Ladies and gentlemen, thank you for standing by. Welcome to the Traws Pharma, Inc. Second Quarter 2025 Financial Results and Business Update Call. [Operator Instructions] As a reminder, this call is being recorded today, August 14, 2025....

Read the full article on Seeking Alpha

For further details see:

Traws Pharma, Inc. (TRAW) Q2 2025 Earnings Call Transcript
Traws Pharma Inc.

NASDAQ: TRAW

TRAW Trading

11.57% G/L:

$1.7405 Last:

1,153,558 Volume:

$1.55 Open:

mwn-app Ad 300

TRAW Latest News

May 08, 2026 03:22:22 pm
Do Not Ignore this Rally

TRAW Stock Data

$15,422,373
6,872,146
2.64%
11
N/A
Biotechnology & Life Sciences
Healthcare
US
Newtown

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App